Detalles de la búsqueda
1.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1224-1233, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888454
2.
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial.
Eur Respir J
; 56(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444410
3.
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 387(10026): 1405-1414, 2016 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719230
4.
[Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer]. / Oligroprogression sous nivolumab du cancer bronchique non à petites cellules métastatiques traitées par radiothérapie.
Bull Cancer
; 110(12): 1234-1243, 2023 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-38445648
5.
Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker.
Cancers (Basel)
; 15(1)2022 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612286
6.
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.
Clin Cancer Res
; 28(18): 4018-4026, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802649
7.
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).
Lung Cancer
; 157: 124-130, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34016488
8.
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).
Cancer Med
; 9(2): 432-439, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747137
9.
Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma.
Medicine (Baltimore)
; 99(3): e18726, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011450
10.
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018.
J Thorac Oncol
; 15(4): 628-636, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31945494
11.
Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes.
JTO Clin Res Rep
; 1(3): 100052, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589947
12.
Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.
J Thorac Oncol
; 14(1): 63-71, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30391573
13.
Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.
Clin Cancer Res
; 25(19): 5759-5765, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31175096
14.
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
Target Oncol
; 13(4): 501-507, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30039345
15.
Second-line treatments of small-cell lung cancers.
Expert Rev Anticancer Ther
; 17(11): 1033-1043, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28849951
16.
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
J Clin Oncol
; 20(1): 247-53, 2002 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11773176
17.
Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
Chin Clin Oncol
; 4(4): 39, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26730751
18.
Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
J Clin Oncol
; 25(25): 3945-51, 2007 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17761978
Resultados
1 -
18
de 18
1
Próxima >
>>